CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients
CXorf48 是实现 CML 患者无治疗缓解的潜在治疗靶点
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/bcj.2017.84
M Matsushita, K Ozawa, T Suzuki, M Nakamura, N Nakano, S Kanchi, D Ichikawa, E Matsuki, M Sakurai, D Karigane, H Kasahara, N Tsukamoto, T Shimizu, T Mori, H Nakajima, S Okamoto, Y Kawakami, Y Hattori